Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-20

FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex's brimonidine tartrate/timolol maleate ophthalmic solution as an Original Application generic to lower intraocular pressure in open-angle gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine tartrate/timolol maleate ophthalmic solution (brimonidine tartrate and timolol maleate)

Snippet

ORIG AP for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)